Paul Tudor Jones Mannkind Corp Transaction History

Tudor Investment Corp Et Al

$19.2 Billion
Q2 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Mannkind Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 135,893 shares of MNKD stock, worth $852,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,893

Previous 134,911 0.73%

Holding current value

$852,049

Previous $611,000 16.04%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $3,977 - $5,332	982 Added 0.73%	135,893 $709,000
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $438,460 - $710,980	134,911 New	134,911 $611,000
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $112,496 - $160,342	-28,480 Reduced 19.65%	116,455 $477,000
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $49,443 - $87,917	16,372 Added 12.73%	144,935 $764,000
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.35 $105,295 - $153,189	-35,216 Reduced 21.5%	128,563 $397,000
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $156,595 - $279,760	58,650 Added 55.79%	163,779 $624,000
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $91,702 - $155,754	35,001 Added 49.91%	105,129 $387,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $284,018 - $376,587	70,128 New	70,128 $306,000
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $70,474 - $106,394	-19,522 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.14 - $6.14 $23,122 - $45,214	-7,364 Reduced 27.39%	19,522 $77,000
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $48,125 - $108,619	26,886 New	26,886 $84,000

Others Institutions Holding MNKD

# of Institutions

219

Shares Held

133M

Call Options Held

1.43M

Put Options Held

851K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.61B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account